The historical rank and industry rank for Precigen's OCF Margin % or its related term are showing as below:
STU:I5X'
s OCF Margin % Range Over the Past 10 Years
Min: -1736.89 Med: -241.24 Max: -25.66
Current: -363.99
During the past 13 years, the highest OCF Margin % of Precigen was -25.66%. The lowest was -1736.89%. And the median was -241.24%.
STU:I5X's OCF Margin % is ranked worse than 69.25% of 956
companies
in the Biotechnology industry
Industry Median: -68.59
vs STU:I5X: -363.99
Precigen OCF Margin % Related Terms
Precigen OCF Margin % Historical Data
* Premium members only.
The historical data trend for Precigen's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:I5X vs KARD, SLBT, GENB: OCF Margin % Comparison
For the Biotechnology subindustry, Precigen's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precigen OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Precigen's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Precigen's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precigen (STU:I5X) has a OCF Margin % of -188.49% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Precigen and its competitors. According to the industry distribution chart, Precigen ranks #662 out of 956 companies in the Biotechnology industry, placing it in the top 69.2%.
Is Precigen's OCF Margin % too high?
Precigen's current OCF Margin % is -188.49%. Based on the distribution chart, Precigen ranks #662 out of 956 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Precigen has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Precigen's OCF Margin % compare to KARD and SLBT?
According to the Biotechnology industry distribution chart, Precigen ranks #662 out of 956 companies for OCF Margin %. This places Precigen in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Precigen and its competitors. Precigen's current OCF Margin % is -188.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precigen stock overvalued right now?
Based on GuruFocus' analysis, Precigen (STU:I5X) is currently considered Fairly Valued. The stock's GF Value™ is €5.31, compared to a current price of €4.92 — trading 7.3% below its estimated fair value. The current OCF Margin % is -188.49%. Precigen's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Precigen (STU:I5X), the current OCF Margin % is -188.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precigen (STU:I5X) Overvalued in 2026?
Based on GuruFocus' analysis, Precigen stock appears to be undervalued.
The current stock price of €4.92 is trading 7.3% below its estimated GF Value™ of €5.31.
GuruFocus considers Precigen to be Fairly Valued.
Key valuation signals for STU:I5X:
OCF Margin %: -188.49%
GF Value™: €5.31 vs. price of €4.92 (7.3% below fair value)
No single metric tells the full story. See the STU:I5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
62GF Score
Get the complete analysis for STU:I5X
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:I5X has been successfully added to your 
